No Data
No Data
GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650
GT Biopharma (GTBP) said Thursday that the US Food and Drug Administration has cleared its investigational new drug application for GTB-3650, allowing the company to proceed with a phase 1 clinical tr
GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study
By Don Nico Forbes Shares in GT Biopharma rose 15% after receiving approval from the U.S. Food and Drug Administration to begin Phase 1 trials for its GTB-3650 treatment for leukemia. Trials are exp
Express News | GT Biopharma Inc: Gtb-3650 Phase 1 Initial Clinical Data Expected in H1 2025
Express News | GT Biopharma Inc: Gtb-5550 Phase 1 Dose Escalation Basket Trial Initiation Expected in 2025
Express News | GT Biopharma Inc: Gtb-5550 Trike Ind Submission for Treatment of B7H3 Positive Solid Tumors Expected in Q1 2025
Express News | GT Biopharma Inc: Gtb-3650 Phase 1 Trial Initiation Expected in H2 2024